Unstable Angina Pectoris: Clinical Trials

30 trials for Unstable Angina Pectoris, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

16 completed, 6 unknown, 3 recruiting, 2 terminated. 11 Not applicable, 9 Phase 4, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable11Completed 5, Unknown 4, Recruiting 1, Terminated 1
Phase 49Completed 7, Unknown 2
Phase 21Terminated 1
Phase 31Completed 1

Follow Unstable Angina Pectoris: new trials by email Literature Review of Unstable Angina Pectoris trials Research Report on Unstable Angina Pectoris

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Characteristics, Frailty, and Prognostic Predictors in Patients Aged 75 and Older With Acute Coronary Syndrome
Percutaneous Coronary Intervention (PCI), Conservative Medical Therapy - ST Elevation (STEMI) Myocardial Infarction, Non ST Elevation Myocardial Infarction (NSTEMI)
RecruitingClinical Center Niš5502026-05-132026-05-15
A Multi-center, Real-World Clinical Trial of caIMR on Two Specific Kinds of Patients.
caIMR - Coronary Microvascular Dysfunction (CMD), Stable Angina Pectoris
Not yet recruitingGe Junbo5082025-07-012025-04-27
Aerobic Exercise-induced Effect on Endothelial Function in Patients With Ischaemic Heart Disease
Aerobic exercise (MIT), Aerobic exercise (Short HIIT), Aerobic exercise (Long HIIT) - Percutaneous Coronary Intervention (PCI), Acute Myocardial Infarction
Not applicableRecruitingInstituto de Investigación Sanitaria y Biomédica de Alicante1322024-11-012026-02-27
The Flash FFR Ⅱ Study
caFFR, FFR - Coronary Artery Disease, Coronary Stenosis
Not applicableUnknownPeking University First Hospital21322021-01-122023-03-21
The International Survey of Acute Coronary Syndromes-ARCHIVES
Non-interventional patient registry - Acute Coronary Syndrome, Unstable Angina Pectoris
Enrolling by invitationUniversity of Bologna1300002019-06-282026-05-01
Efficacy and Safety of Low Dose Ticagrelor in Patients With Unstable Angina Pectoris After Coronary Stent Implantation
Ticagrelor 90 mg, Ticagrelor 45 mg, Aspirin - Unstable Angina Pectoris, Coronary Stent Implantation
Phase 4UnknownXiaofan Wu20362018-08-072018-12-24
Safety and Efficacy of Low Temperature Contrast in UAP Patients During PCI (LOTA-I)
low temperature contrast - Unstable Angina Pectoris
Not applicableCompletedNanjing First Hospital, Nanjing Medical University4402018-08-012023-11-18
PCB for Long De Novo Lesions of Main Coronary Arteries (D-Lesion Long Trial)
Paclitaxel-Coated Balloon - Stable Angina Pectoris, Unstable Angina Pectoris
Not applicableUnknownThe People's Hospital of Liaoning Province602017-07-012017-05-16
Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents
Orsiro, Resolute Onyx - Coronary Artery Disease, Angina Pectoris
Not applicableUnknownThorax Centrum Twente24702016-10-072017-02-03
Influence of Naloxone on Ticagrelor Pharmacokinetics and Pharmacodynamics in Patients With Unstable Angina Pectoris on Concomitant Treatment With Morphine
Crushed ticagrelor followed by morphine, Crushed ticagrelor, morphine,naloxone - Unstable Angina Pectoris
Phase 4CompletedCollegium Medicum w Bydgoszczy302016-10-012019-04-01
Influence of Metoclopramide on Ticagrelor Pharmacokinetics and Pharmacodynamics in Patients With Unstable Angina Pectoris on Concomitant Treatment With Morphine
Crushed ticagrelor followed by morphine, Crushed ticagrelor, morphine,metoclopramide - Unstable Angina Pectoris
Phase 4CompletedCollegium Medicum w Bydgoszczy322016-07-012019-04-01
A Comparative Evaluation of the Extent of Neointima Formation at 1 Month and 2 Months After Implantation Using OCT
BuMA Supreme™ stent, Xience V/Prime stent - Coronary Artery Disease, Stable Angina Pectoris
Not applicableCompletedSino Medical Sciences Technology Inc.822016-06-152021-10-13
Comparison of Administration Strategies of Ticagrelor in Patients With Unstable Angina Pectoris, a Pharmacokinetic / Pharmacodynamic Study
Pulverized ticagrelor sublingually, Pulverized ticagrelor orally, Integral ticagrelor - Unstable Angina Pectoris
Phase 4CompletedCollegium Medicum w Bydgoszczy492015-09-012016-10-19
High-intensity Exercise After Acute Cardiac Event (HITCARE)
High-intensity aerobic interval training, short interval, High-intensity aerobic interval training, long interval - Unstable Angina Pectoris, Acute Myocardial Infarction
Not applicableTerminatedKuopio Research Institute of Exercise Medicine272014-12-012017-01-24
BASIC VALIDATE Coronary Stent Registry
Coronary stenting with CE-marked stent - Myocardial Infacrtion, Unstable Angina Pectoris
WithdrawnRegion Örebro County2014-06-012023-03-29
Opsens Optowire for Fractional Flow Reserve - The O2 Pilot Study
Fractional flow reserve measurement - Stable Angina, Unstable Angina Pectoris
Not applicableCompletedLaval University602014-05-012015-07-10
Danhong Injection in the Treatment of Unstable Angina Pectoris
Danhong injection, Standard medical care, Placebo - Unstable Angina Pectoris
Phase 4CompletedChina Academy of Chinese Medical Sciences1602013-12-012017-12-02
BuMA OCT Study(A Comparative Evaluation of the Extent of Neointima Formation at 3 Months After Implantation Using OCT)
BuMA stent, EXCEL stent - Coronary Heart Disease, Stable Angina Pectoris
Not applicableCompletedSino Medical Sciences Technology Inc.802012-12-012016-03-14
DUrable Polymer-based STent CHallenge of Promus ElemEnt Versus ReSolute Integrity
Resolute Integrity®, Promus Element® - Coronary Artery Disease, Angina Pectoris
Not applicableUnknownThorax Centrum Twente18112010-11-012017-02-03
International Survey of Acute Coronary Syndromes
Acute Coronary Syndrome, Unstable Angina Pectoris
RecruitingUniversity of Bologna360002010-09-282025-04-16

Showing 20 of 30. Sign in to see all of them.

Narrower conditions

Angina, Unstable (30)  ·  Angina, Stable (12)  ·  Coronary Artery Disease (10)  ·  Myocardial Infarction (10)  ·  Acute Coronary Syndrome (8)  ·  Angina Pectoris (5)  ·  Coronary Stenosis (5)  ·  Chest Pain (3)  ·  Coronary Disease (3)  ·  Coronary Restenosis (3)  ·  Emergencies (2)  ·  Neointima (2)  ·  Atherosclerosis (1)  ·  Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 2 (1)

Broader conditions

Cardiovascular Diseases (30)  ·  Heart Diseases (30)  ·  Neurologic Manifestations (30)  ·  Pain (30)  ·  Pathological Conditions, Signs and Symptoms (30)  ·  Signs and Symptoms (30)  ·  Vascular Diseases (30)  ·  Myocardial Ischemia (29)  ·  Chest Pain (27)  ·  Angina Pectoris (25)  ·  Pathologic Processes (13)  ·  Coronary Disease (11)  ·  Arterial Occlusive Diseases (10)  ·  Arteriosclerosis (10)  ·  Infarction (10)

Interventions

Ticagrelor (4)  ·  Morphine (2)  ·  Aspirin (1)  ·  Atorvastatin (1)  ·  Exercise (1)  ·  Fluvastatin (1)  ·  Fractional Flow Reserve, Myocardial (1)  ·  Hydroxymethylglutaryl-CoA Reductase Inhibitors (1)  ·  Metoclopramide (1)  ·  Naloxone (1)  ·  Percutaneous Coronary Intervention (1)  ·  Pravastatin (1)  ·  Simvastatin (1)  ·  Sitagliptin Phosphate (1)  ·  danhong (1)

Sponsors

Collegium Medicum w Bydgoszczy (3)  ·  Helse Stavanger HF (2)  ·  Massachusetts General Hospital (2)  ·  Peking University First Hospital (2)  ·  Sino Medical Sciences Technology Inc. (2)  ·  Thorax Centrum Twente (2)  ·  University of Bologna (2)  ·  Atlantic Health System (1)  ·  China Academy of Chinese Medical Sciences (1)  ·  Clinical Center Niš (1)  ·  Foundation of Cardiovascular Research and Education Enschede (1)  ·  Ge Junbo (1)  ·  Instituto de Investigación Sanitaria y Biomédica de Alicante (1)  ·  Karolinska Institutet (1)  ·  Kuopio Research Institute of Exercise Medicine (1)

Countries

China (8)  ·  Netherlands (3)  ·  Norway (3)  ·  Poland (3)  ·  United States (3)  ·  Italy (2)  ·  Argentina (1)  ·  Belgium (1)  ·  Canada (1)  ·  Finland (1)  ·  Israel (1)  ·  Japan (1)  ·  Serbia (1)  ·  Spain (1)  ·  Sweden (1)

Top investigators

Jacek Kubica, MD., PhD. (3)  ·  Raffaele Bugiardini, MD (2)  ·  Udo Hoffmann, MD, MPH (2)  ·  Yong Huo, MD (2)  ·  Aijie Hou (1)  ·  C. von Birgelen, MD,PhD,Prof (1)  ·  Clemens von Birgelen, MD, PhD (1)  ·  Clemens von Birgelen, MD,PhD,Prof (1)  ·  Dennis WT Nilsen, MD PhD FESC (1)  ·  Dennis WT Nilsen, MD PhD Prof. (1)  ·  Emil Bisaccia, MD (1)  ·  Fei Ye, MD (1)  ·  Kenya Nasu, MD (1)

Results publications

PMID 28923845, PMID 32654558, PMID 33766254, PMID 34237166, PMID 34251454, PMID 34649504, PMID 35589164, PMID 35641327, PMID 37619976, PMID 37745109, PMID 40687396, PMID 16650886, PMID 17075011, PMID 17111198, PMID 17492403, PMID 18556107, PMID 18832914, PMID 19032759, PMID 19054318, PMID 19158216, PMID 19406338, PMID 19696685, PMID 19718477, PMID 19781415, PMID 19809305, PMID 20028530, PMID 20484542, PMID 21524564, PMID 21958326, PMID 22341737, PMID 22424002, PMID 22456695, PMID 22581199, PMID 22830462, PMID 22970121, PMID 23127172, PMID 23359390, PMID 23406538, PMID 23602769, PMID 23685743, PMID 23819097, PMID 24021693, PMID 24349821, PMID 24585502, PMID 24628779, PMID 25125300, PMID 25339110, PMID 25710925, PMID 25722531, PMID 25752898

NIH funding

R01HL080053 (1)